CARLY MIROWITZ: Open Payments
NPI 1679090625 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,041 in 48 payments from 18 companies in 2025. Trend: 2023 $59 · 2024 $1,093 · 2025 $1,041
Food & beverage: $1,041
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $295 |
| Lilly USA, LLC | 6 | $120 |
| AstraZeneca Pharmaceuticals LP | 4 | $93 |
| Novo Nordisk Inc | 4 | $78 |
| ViiV Healthcare Company | 3 | $65 |
| Collegium Pharmaceutical, Inc. | 3 | $60 |
| PFIZER INC. | 3 | $59 |
| Exact Sciences Corporation | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $35 |
| BIOTRONIK NRO, Inc. | 1 | $25 |
Products named: VRAYLAR, MOUNJARO, BREZTRI, QULIPTA, Wegovy, APRETUDE, Jornay PM, REXULTI.
Industry payments across IL — which companies pay providers there.
